KBC Group NV

Position in BMY — Bristol Myers Squibb Co

CIK 1411133 Brussels, C9

Back to BMY Full portfolio

Position in BMY

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$245,712,249

+$2,553,967 QoQ

Shares Held

4,264,357

+6.4% QoQ

Ownership

0.209%

of shares outstanding

% of Portfolio

0.53%

of 13F equity value

Holder Rank

#62

of 2,514 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Common Shares in BMY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

KBC Group NV holds $2,157,048,254 across 10 Drug Manufacturers - General names. BMY ranks #3 (11.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	544,998	$653,687,004
2	JNJ	Johnson & Johnson	1,322,168	$335,791,005
3	BMY	Bristol Myers Squibb Co This page	4,264,357	$245,712,249
4	GILD	Gilead Sciences, Inc.	1,644,035	$207,707,380
5	PFE	Pfizer Inc	8,327,265	$200,520,541
6	ABBV	AbbVie Inc.	672,932	$169,336,607
7	MRK	Merck & Co., Inc.	1,131,286	$145,370,250
8	AMGN	Amgen Inc	382,676	$138,574,632

All Filings in BMY

Export CSV

26 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$245,712,249	4,264,357	+6.4%	Shares	Defined	2026-08-05
2026-03-31	$243,158,282	4,009,205	+1.1%	Shares	Defined	2026-05-07
2025-12-31	$213,986,505	3,967,121	-2.5%	Shares	Defined	2026-01-26
2025-09-30	$183,552,985	4,069,911	+1.3%	Shares	Defined	2026-01-20
2025-06-30	$186,065,849	4,019,569	+4.4%	Shares	Defined	2025-08-08
2025-03-31	$234,786,798	3,849,595	-5.1%	Shares	Defined	2025-04-25
2024-12-31	$229,343,333	4,054,868	+18.4%	Shares	Defined	2025-01-22
2024-09-30	$177,259,169	3,425,960	-39.0%	Shares	Defined	2024-11-06
2024-06-30	$233,246,059	5,616,327	+6.1%	Shares	Defined	2024-07-17
2024-03-31	$287,179,845	5,295,590	+86.0%	Shares	Defined	2024-05-08
2023-12-31	$146,100,093	2,847,400	+92.4%	Shares	Defined	2024-02-13
2023-09-30	$85,913,651	1,480,249	-31.4%	Shares	Defined	2024-02-15
2023-06-30	$137,939,638	2,156,992	+43.8%	Shares	Defined	2024-02-15
2023-03-31	$103,983,574	1,500,268	-16.4%	Shares	Defined	2024-02-14
2022-12-31	$129,067,363	1,793,848	-36.5%	Shares	Defined	2024-02-14
2022-09-30	$200,892,946	2,825,896	-8.9%	Shares	Defined	2024-02-15
2022-06-30	$238,786,702	3,101,126	+2.6%	Shares	Defined	2024-02-14
2022-03-31	$220,659,925	3,021,497	+9.9%	Shares	Defined	2024-02-14
2021-12-31	$171,377,952	2,748,644	+1.2%	Shares	Defined	2024-02-14
2021-09-30	$160,695,897	2,715,834	+6.7%	Shares	Defined	2021-11-10
2021-06-30	$170,047,077	2,544,853	+10.7%	Shares	Defined	2022-02-15
2021-03-31	$145,123,495	2,298,804	+5.0%	Shares	Defined	2022-02-14
2020-12-31	$135,839,186	2,189,895	+28.4%	Shares	Defined	2022-02-14
2020-09-30	$102,821,700	1,705,452	+11.5%	Shares	Defined	2022-02-14
2020-06-30	$89,898,379	1,528,884	+81.4%	Shares	Defined	2022-02-14
2020-03-31	$46,990,101	843,023	—	Shares	Defined	2020-05-04
No filing history on record for this holder in this stock.